These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 17709266)

  • 1. Frequent intravenous pulses of growth hormone together with alanylglutamine supplementation in prolonged critical illness after multiple trauma: effects on glucose control, plasma IGF-I and glutamine.
    Duska F; Fric M; Pazout J; Waldauf P; Tůma P; Pachl J
    Growth Horm IGF Res; 2008 Feb; 18(1):82-7. PubMed ID: 17709266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent intravenous pulses of growth hormone together with glutamine supplementation in prolonged critical illness after multiple trauma: effects on nitrogen balance, insulin resistance, and substrate oxidation.
    Duska F; Fric M; Waldauf P; Pazout J; Andel M; Mokrejs P; Tůma P; Pachl J
    Crit Care Med; 2008 Jun; 36(6):1707-13. PubMed ID: 18496372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum concentration of IGFBP-4 and IGFBP-5 in healthy adults during one month's treatment with supraphysiological doses of growth hormone.
    Ehrnborg C; Ohlsson C; Mohan S; Bengtsson BA; Rosén T
    Growth Horm IGF Res; 2007 Jun; 17(3):234-41. PubMed ID: 17347011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of increasing dosages of glycyl-glutamine for total parenteral nutrition in polytrauma patients.
    Weingartmann G; Fridrich P; Mauritz W; Götzinger P; Mittlböck M; Germann P; Karner J; Roth E
    Wien Klin Wochenschr; 1996; 108(21):683-8. PubMed ID: 8956477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children.
    Codner E; Cassorla F; Tiulpakov AN; Mericq MV; Avila A; Pescovitz OH; Svensson J; Cerchio K; Krupa D; Gertz BJ; Murphy G
    Clin Pharmacol Ther; 2001 Jul; 70(1):91-8. PubMed ID: 11452249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
    Williams RM; Yuen K; White D; Mallard B; Dalton RN; Acerini CL; Dunger DB
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamine enhances the gut-trophic effect of growth hormone in rat after massive small bowel resection.
    Zhou X; Li YX; Li N; Li JS
    J Surg Res; 2001 Jul; 99(1):47-52. PubMed ID: 11421603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty-four hour GH secretion and IGF-related parameters.
    Christiansen JJ; Gravholt CH; Fisker S; Svenstrup B; Bennett P; Veldhuis J; Andersen M; Christiansen JS; Jørgensen JO
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):461-9. PubMed ID: 15049961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does growth hormone allow more efficient nitrogen sparing in postoperative patients requiring parenteral nutrition? A double-blind, placebo-controlled randomised trial.
    Sevette A; Smith RC; Aslani A; Kee AJ; Hansen R; Barratt SM; Baxter RC
    Clin Nutr; 2005 Dec; 24(6):943-55. PubMed ID: 16083996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
    Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB
    Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lycopene supplementation on insulin-like growth factor-1 and insulin-like growth factor binding protein-3: a double-blind, placebo-controlled trial.
    Graydon R; Gilchrist SE; Young IS; Obermüller-Jevic U; Hasselwander O; Woodside JV
    Eur J Clin Nutr; 2007 Oct; 61(10):1196-200. PubMed ID: 17299493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of parenteral glutamine supplementation on glucose homeostasis in critically ill polytrauma patients--A randomized-controlled clinical study.
    Grintescu IM; Luca Vasiliu I; Cucereanu Badica I; Mirea L; Pavelescu D; Balanescu A; Grintescu IC
    Clin Nutr; 2015 Jun; 34(3):377-82. PubMed ID: 24931756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of the steroids, SHBG, IGF-1, IGF BP-3 and growth hormone in glucose metabolism disorders during long-term treatment with low doses of glucocorticoids].
    Vondra K; Hampl R; Nĕmcová D; Hill M; Hoza J; Kot'átková A; Stárka L; Vrbíková J; Zamrazil V
    Cas Lek Cesk; 2002 Feb; 141(3):89-95. PubMed ID: 11925670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic effects of enteral versus parenteral alanyl-glutamine dipeptide administration in critically ill patients receiving enteral feeding: a pilot study.
    Luo M; Bazargan N; Griffith DP; Estívariz CF; Leader LM; Easley KA; Daignault NM; Hao L; Meddings JB; Galloway JR; Blumberg JB; Jones DP; Ziegler TR
    Clin Nutr; 2008 Apr; 27(2):297-306. PubMed ID: 18258342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenterally administered dipeptide alanyl-glutamine prevents worsening of insulin sensitivity in multiple-trauma patients.
    Bakalar B; Duska F; Pachl J; Fric M; Otahal M; Pazout J; Andel M
    Crit Care Med; 2006 Feb; 34(2):381-6. PubMed ID: 16424718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.